Aehr Test Systems(DE:AYB)
€60.98+7.54 (+14.11%)
DE:AYB
Aehr Test Systems financials statements
€60.98
At close:+7.54 (+14.11%)
Aehr Test Systems (AYB) Ratios
8 Followers
Aehr Test Systems Ratios
DE:AYB's free cash flow for Q1 2027 was $-3.10M. For the 2027 fiscal year, DE:AYB's free cash flow was decreased by $-49.00K and operating cash flow was $-3.05M. See a summary of the company’s cash flow.
| Ratios | May 26 | May 25 | May 24 | May 23 | May 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 10.33 | 5.68 | 9.31 | 5.46 | 5.45 |
| Quick Ratio | 8.01 | 2.99 | 5.75 | 3.99 | 4.08 |
| Cash Ratio | 6.52 | 1.61 | 4.68 | 1.84 | 2.86 |
| Solvency Ratio | -0.13 | -0.02 | 2.12 | 0.67 | 0.86 |
| Operating Cash Flow Ratio | -0.19 | -0.47 | 0.17 | 0.61 | 0.14 |
| Short-Term Operating Cash Flow Coverage | -5.29 | -8.14 | 3.78 | 73.07 | 1.90 |
| Net Current Asset Value | $ 157.26M | $ 63.14M | $ 81.53M | $ 66.49M | $ 48.67M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.04 | 0.07 | 0.05 | 0.06 | 0.02 |
| Debt-to-Equity Ratio | 0.05 | 0.09 | 0.06 | 0.08 | 0.02 |
| Debt-to-Capital Ratio | 0.04 | 0.08 | 0.05 | 0.08 | 0.02 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.12 | 1.21 | 1.15 | 1.30 | 1.22 |
| Debt Service Coverage Ratio | -5.74 | -0.57 | 74.23 | 109.54 | 12.29 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.32 | 0.37 | 0.22 | 0.23 | 0.04 |
| Net Debt to EBITDA | 12.98 | 15.95 | -3.11 | -1.58 | -3.09 |
| Profitability Margins | |||||
| Gross Profit Margin | 35.30% | 40.59% | 49.15% | 50.41% | 46.56% |
| EBIT Margin | -23.47% | -7.28% | 18.81% | 22.50% | 18.77% |
| EBITDA Margin | -16.41% | -1.53% | 20.87% | 23.19% | 19.37% |
| Operating Profit Margin | -28.30% | -7.31% | 15.22% | 20.59% | 15.35% |
| Pretax Profit Margin | -23.47% | -7.28% | 18.81% | 22.50% | 18.77% |
| Net Profit Margin | -14.25% | -6.63% | 50.07% | 22.41% | 18.59% |
| Continuous Operations Profit Margin | -14.25% | -6.63% | 50.07% | 22.41% | 18.59% |
| Net Income Per EBT | 60.72% | 91.12% | 266.14% | 99.59% | 99.05% |
| EBT Per EBIT | 82.95% | 99.49% | 123.62% | 109.29% | 122.32% |
| Return on Assets (ROA) | -2.89% | -2.63% | 25.92% | 14.83% | 15.16% |
| Return on Equity (ROE) | -3.25% | -3.18% | 29.71% | 19.26% | 18.53% |
| Return on Capital Employed (ROCE) | -6.18% | -3.25% | 8.58% | 16.34% | 15.20% |
| Return on Invested Capital (ROIC) | -3.74% | -2.94% | 8.55% | 16.25% | 14.83% |
| Return on Tangible Assets | -3.15% | -3.08% | 25.92% | 14.83% | 15.16% |
| Earnings Yield | -0.25% | -1.39% | 10.00% | 1.59% | 4.33% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.86 | 3.31 | 6.62 | 3.91 | 3.95 |
| Payables Turnover | 4.79 | 5.21 | 6.32 | 3.50 | 6.48 |
| Inventory Turnover | 0.78 | 0.83 | 0.90 | 1.35 | 1.80 |
| Fixed Asset Turnover | 2.80 | 3.18 | 7.37 | 7.31 | 23.98 |
| Asset Turnover | 0.20 | 0.40 | 0.52 | 0.66 | 0.82 |
| Working Capital Turnover Ratio | 0.42 | 0.73 | 0.83 | 1.07 | 1.72 |
| Cash Conversion Cycle | 517.94 | 477.56 | 403.44 | 259.81 | 238.21 |
| Days of Sales Outstanding | 127.55 | 110.12 | 55.10 | 93.24 | 92.34 |
| Days of Inventory Outstanding | 466.59 | 437.53 | 406.13 | 270.88 | 202.24 |
| Days of Payables Outstanding | 76.20 | 70.09 | 57.79 | 104.31 | 56.37 |
| Operating Cycle | 594.14 | 547.65 | 461.23 | 364.12 | 294.58 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.11 | -0.25 | 0.06 | 0.36 | 0.06 |
| Free Cash Flow Per Share | -0.18 | -0.42 | 0.03 | 0.31 | 0.04 |
| Dividend Paid and CapEx Coverage Ratio | -1.60 | -1.48 | 2.34 | 7.35 | 3.63 |
| Capital Expenditure Coverage Ratio | -1.60 | -1.48 | 2.34 | 7.35 | 3.63 |
| Operating Cash Flow Coverage Ratio | -0.33 | -0.68 | 0.28 | 1.59 | 1.50 |
| Operating Cash Flow to Sales Ratio | -0.07 | -0.13 | 0.03 | 0.15 | 0.03 |
| Free Cash Flow Yield | -0.19% | -4.39% | 0.30% | 0.94% | 0.50% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -401.43 | -73.38 | 10.00 | 63.03 | 23.07 |
| Price-to-Sales (P/S) Ratio | 56.63 | 4.79 | 5.01 | 14.12 | 4.29 |
| Price-to-Book (P/B) Ratio | 12.90 | 2.30 | 2.97 | 12.14 | 4.28 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -526.72 | -22.77 | 329.39 | 106.08 | 199.63 |
| Price-to-Operating Cash Flow Ratio | -855.49 | -38.14 | 188.89 | 91.65 | 144.56 |
| Price-to-Earnings Growth (PEG) Ratio | -5.22 | 0.66 | 0.08 | 1.42 | -0.04 |
| Enterprise Value Multiple | -332.10 | -296.57 | 20.89 | 59.32 | 19.04 |
| Enterprise Value | 2.73B | 267.80M | 288.73M | 893.71M | 187.52M |
| EV to EBITDA | -332.10 | -296.57 | 20.89 | 59.32 | 19.04 |
| EV to Sales | 54.50 | 4.54 | 4.36 | 13.76 | 3.69 |
| EV to Free Cash Flow | -506.92 | -21.61 | 286.73 | 103.33 | 171.72 |
| EV to Operating Cash Flow | -823.32 | -36.19 | 164.43 | 89.27 | 124.35 |
| Tangible Book Value Per Share | 6.50 | 3.43 | 3.87 | 2.72 | 1.96 |
| Shareholders’ Equity Per Share | 7.16 | 4.15 | 3.87 | 2.72 | 1.96 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.39 | 0.09 | -1.66 | 0.00 | 0.01 |
| Revenue Per Share | 1.63 | 1.99 | 2.30 | 2.34 | 1.95 |
| Net Income Per Share | -0.23 | -0.13 | 1.15 | 0.52 | 0.36 |
| Tax Burden | 0.61 | 0.91 | 2.66 | 1.00 | 0.99 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.25 | 0.18 | 0.13 | 0.11 | 0.11 |
| SG&A to Revenue | 0.38 | 0.30 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.14 | 0.09 | 0.04 | 0.00 | 0.06 |
| Income Quality | 0.46 | 1.89 | 0.05 | 0.69 | 0.16 |
Currency in USD
